Unichem Laboratories rises on getting ANDA approval for Celecoxib Capsules

13 Jan 2021 Evaluate

Unichem Laboratories is currently trading at Rs. 278.05, up by 0.40 points or 0.14% from its previous closing of Rs. 277.65 on the BSE.

The scrip opened at Rs. 279.80 and has touched a high and low of Rs. 284.50 and Rs. 275.90 respectively. So far 10498 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 304.20 on 04-Aug-2020 and a 52 week low of Rs. 75.10 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 289.25 and Rs. 262.05 respectively. The current market cap of the company is Rs. 1978.40 crore.

The promoters holding in the company stood at 50.93%, while Institutions and Non-Institutions held 10.77% and 38.29% respectively.

Unichem Laboratories has received ANDA approval for its Celecoxib Capsules, 50 mg, 100 mg, 200 mg, and 400 mg from the United States Food and Drug Administration (USFDA) to market a generic version of CELEBREX (Celecoxib) Capsules of G.D. Searle LLC, Division of Pfizer Inc.

Celecoxib capsules are indicated for treatment of Osteoarthritis, Rheumatoid Arthritis Juvenile Rheumatoid Arthritis, Ankylosing Spondylitis, Acute Pain and Primary Dysmenorrhea. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

552.00 4.30 (0.79%)
14-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1515.00
Dr. Reddys Lab 6080.25
Cipla 1565.50
Zydus Lifesciences 1110.95
Lupin 1601.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.